TuHURA Biosciences Appoints SVP of Clinical Operations

TuHURA Biosciences, Inc., a Phase 3 immuno-oncology company, has appointed Amanda Garofalo, MSHS, as its new Senior Vice President of Clinical Operations. Garofalo's extensive experience is expected to bolster the company's efforts in developing novel therapeutics aimed at overcoming challenges in cancer treatment. Her appointment signifies a strategic move to strengthen the leadership team as TuHURA advances its clinical pipeline. This addition is crucial for driving forward the company's mission in the competitive field of oncology drug development.